Cite
HARVARD Citation
Bawazeer, A. et al. (2021). Interleukin‐1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection. Immunology and cell biology. 99 (7), pp. 737-748. [Online].